Medesis Pharma SA (ALMDP) — Cash Flow Reinvestment Rate
Latest as of December 2020:
0.00x
Medesis Pharma SA (ALMDP) has a Cash Flow Reinvestment Rate of 0.00x as of December 2020, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €185.83K. See financial agility of Medesis Pharma SA to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
€0.00
Capex + Investments
Operating Cash Flow
€185.83K
EUR
Capital Expenditures
€0.00
EUR
Medesis Pharma SA Cash Flow Reinvestment Rate (2019–2020)
Historical reinvestment intensity for Medesis Pharma SA across 2 annual periods. Explore ALMDP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Medesis Pharma SA (2019–2020)
Year-by-year capital reinvestment analysis for Medesis Pharma SA. For the full cash flow conversion analysis, see Medesis Pharma SA cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | €0.00 | €185.83K | €0.00 | — |
| 2019 | 0.00x | €0.00 | €333.76K | €0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow